382 related articles for article (PubMed ID: 16097954)
1. Maternal valproate dosage and foetal malformations.
Vajda FJ; Eadie MJ
Acta Neurol Scand; 2005 Sep; 112(3):137-43. PubMed ID: 16097954
[TBL] [Abstract][Full Text] [Related]
2. The prescribing of antiepileptic drugs for pregnant Australian women.
Vajda FJ; Horgan D; Hollingworth S; Graham J; Hitchcock AA; Roten A; O'Brien TJ; Lander CM; Eadie MJ
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):49-53. PubMed ID: 21910695
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
[TBL] [Abstract][Full Text] [Related]
4. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy.
Vajda FJ; O'brien TJ; Hitchcock A; Graham J; Cook M; Lander C; Eadie MJ
J Clin Neurosci; 2004 Nov; 11(8):854-8. PubMed ID: 15519862
[TBL] [Abstract][Full Text] [Related]
5. Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J
Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656
[TBL] [Abstract][Full Text] [Related]
6. Dose dependence of fetal malformations associated with valproate.
Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
[TBL] [Abstract][Full Text] [Related]
7. Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study.
Dravet C; Julian C; Legras C; Magaudda A; Guerrini R; Genton P; Soulayrol S; Giraud N; Mesdjian E; Trentin G
Neurology; 1992 Apr; 42(4 Suppl 5):75-82. PubMed ID: 1574181
[TBL] [Abstract][Full Text] [Related]
8. Valproate teratogenicity and epilepsy syndrome.
Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
[TBL] [Abstract][Full Text] [Related]
9. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
[TBL] [Abstract][Full Text] [Related]
10. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring.
Artama M; Auvinen A; Raudaskoski T; Isojärvi I; Isojärvi J
Neurology; 2005 Jun; 64(11):1874-8. PubMed ID: 15955936
[TBL] [Abstract][Full Text] [Related]
11. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
[TBL] [Abstract][Full Text] [Related]
12. The teratogenic risk of antiepileptic drug polytherapy.
Vajda FJ; Hitchcock AA; Graham J; O'Brien TJ; Lander CM; Eadie MJ
Epilepsia; 2010 May; 51(5):805-10. PubMed ID: 19817810
[TBL] [Abstract][Full Text] [Related]
13. Changing patterns of antiepileptic drug use in pregnant Australian women.
Vajda FJ; Hollingworth S; Graham J; Hitchcock AA; O'Brien TJ; Lander CM; Eadie MJ
Acta Neurol Scand; 2010 Feb; 121(2):89-93. PubMed ID: 20015108
[TBL] [Abstract][Full Text] [Related]
14. Changing Australian prescribing patterns for antiepileptic drugs in pregnancy and their possible consequences.
Vajda FJ; Lander CM; Hitchcock A; Graham J; Solinas C; O'Brien T; Eadie MJ
J Clin Neurosci; 2007 Jul; 14(7):611-7. PubMed ID: 17400456
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the hazard of foetal malformation in pregnant women with epilepsy.
Vajda FJ; O'Brien TJ; Graham J; Lander CM; Eadie MJ
Epilepsy Res; 2014 Aug; 108(6):1013-7. PubMed ID: 24880523
[TBL] [Abstract][Full Text] [Related]
16. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.
Campbell E; Kennedy F; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ; Craig J; Morrow J
J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1029-34. PubMed ID: 24444855
[TBL] [Abstract][Full Text] [Related]
17. Valproate-associated foetal malformations-Rates of occurrence, risks in attempted avoidance.
Vajda FJE; O'Brien TJ; Graham JE; Hitchcock AA; Lander CM; Eadie MJ
Acta Neurol Scand; 2019 Jan; 139(1):42-48. PubMed ID: 30109700
[TBL] [Abstract][Full Text] [Related]
18. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
Tomson T; Perucca E; Battino D
Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
[TBL] [Abstract][Full Text] [Related]
20. Comparative safety of antiepileptic drugs during pregnancy.
Hernández-Díaz S; Smith CR; Shen A; Mittendorf R; Hauser WA; Yerby M; Holmes LB; ;
Neurology; 2012 May; 78(21):1692-9. PubMed ID: 22551726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
